KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Short term Debt (2016 - 2026)

Medtronic (MDT) has disclosed Short term Debt for 13 consecutive years, with $191.0 million as the latest value for Q1 2026.

  • Quarterly Short term Debt fell 92.72% to $191.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $191.0 million through Jan 2026, down 92.72% year-over-year, with the annual reading at $2.9 billion for FY2025, 163.19% up from the prior year.
  • Short term Debt hit $191.0 million in Q1 2026 for Medtronic, down from $1.4 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $5.9 billion in Q1 2023 to a low of $20.0 million in Q2 2023.
  • Historically, Short term Debt has averaged $2.4 billion across 5 years, with a median of $1.6 billion in 2024.
  • Biggest five-year swings in Short term Debt: soared 95383.33% in 2022 and later tumbled 99.47% in 2023.
  • Year by year, Short term Debt stood at $5.9 billion in 2022, then tumbled by 77.17% to $1.3 billion in 2023, then skyrocketed by 177.74% to $3.7 billion in 2024, then crashed by 61.82% to $1.4 billion in 2025, then tumbled by 86.55% to $191.0 million in 2026.
  • Business Quant data shows Short term Debt for MDT at $191.0 million in Q1 2026, $1.4 billion in Q4 2025, and $2.4 billion in Q3 2025.